Institution view

RenJi Hospital

Programs currently tracked for this institution in the public Translational Deal Radar dataset.

Car Nk

ACT-001 CAR-NK cell

ACT-001 CAR-NK cell is flagged as a platform signal because it has an active early-phase oncology cell-therapy trial at RenJi Hospital, with a possible patent signal linked through modality_match. Manual review is still required.

Na · Not Yet Recruiting

View asset